The Board of Directors of Ensurge Micropower ASA ("Ensurge") approved the annual report and the annual financial statements ...

Natasha Cazenave, executive director of the European Securities and Markets Authority (ESMA), addressed the European ...

American Financial Group, Inc. (NYSE: AFG) announced today that a wholly-owned subsidiary of AFG has reached agreements ("Agreements") to sell the hotel and related assets and the marina comprising ...

Thank you, Betsy, and good morning, everyone. Welcome to Truist's First Quarter 2025 Earnings Call. With us today are our Chairman and CEO, Bill Rogers; our CFO, Mike Maguire; our Chief Risk Officer, ...

Q1 2025 Earnings Call Transcript April 17, 2025 Truist Financial Corporation misses on earnings expectations. Reported EPS is ...

Revenue and Sales Performance: For the fiscal third quarter of 2025, Biomerica reported net sales of $1.10 million, a 10% increase from $1.00 million recorded in the same quarter of the previous year.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its ...

DALTON, GA / ACCESS Newswire / April 10, 2025 / The Dixie Group, Inc. (OTCQB:DXYN) today reported financial results for the fourth quarter and the year ended December 28, 2024.In the fourth quarter of ...

BOSTON and LONDON, April 16, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody drug conjugates (ADC) ...

Fully repositioned as a pure-play natural-based product company following strategic review ... For reference, the Company's consolidated financial statements as of December 31, 2024 and for the years ...

“Given 23andMe’s reported financial ... in a statement. Among the services the company provided included kits to analyze your ancestry. If you previously had your saliva sample and DNA stored ...

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in ...